Welcome to LookChem.com Sign In|Join Free

CAS

  • or

131041-99-1

N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

131041-99-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 131041-99-1 Structure

  • Basic information

    1. Product Name: N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE
    2. Synonyms: N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE
    3. CAS NO:131041-99-1
    4. Molecular Formula: C7H14N2O3
    5. Molecular Weight: 175.18
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 131041-99-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE(131041-99-1)
    11. EPA Substance Registry System: N-HYDROXY-2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ACETIMIDAMIDE(131041-99-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 131041-99-1(Hazardous Substances Data)

131041-99-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 131041-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,0,4 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 131041-99:
(8*1)+(7*3)+(6*1)+(5*0)+(4*4)+(3*1)+(2*9)+(1*9)=81
81 % 10 = 1
So 131041-99-1 is a valid CAS Registry Number.

131041-99-1Relevant articles and documents

COMPOUNDS AND USES THEREOF

-

Page/Page column 78, (2021/03/19)

The present invention relates to compositions and methods for the treatment of HA01 -associated disorders, such as primary hyperoxaluria 1.

Tetrahydropyridyloxadiazoles: Semirigid Muscarinic Ligands

Showell, Graham A.,Gibbons, Tracey L.,Kneen, Clare O.,MacLeod, Angus M.,Merchant, Kevin,et al.

, p. 1086 - 1094 (2007/10/02)

Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites.The current paper describes the synthesis and biochemical assesment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation.Analogues 6 and 9 provide high-efficacy muscarinic agonist at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy.Molecular mechanics calculations indicated a preference for the E rotameric form.This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12.The new compounds were tested in biochemical assay designed to measure receptor affinity and to predict cortical efficacy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 131041-99-1